Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Item
http://www.wikidata.org/entity/Q33320029
How we diagnose neutropenia in the adult and elderly patientPhase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaLate-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.The late adverse events of rituximab therapy--rare but there!Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.A Case of an Acquired Factor VIII Inhibitor Complicated by Multiple Treatment-Related Opportunistic Infections and Review of the Literature.Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab.How we diagnose and treat neutropenia in adults.Late-onset neutropenia after rituximab in ANCA-associated vasculitis.Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation.Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma.
P2860

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Item
http://www.wikidata.org/entity/Q33320029
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@ast
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@en
Late-onset neutropenia associa ...... for a maturation arrest at the
@nl
type
label
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@ast
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@en
Late-onset neutropenia associa ...... for a maturation arrest at the
@nl
prefLabel
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@ast
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@en
Late-onset neutropenia associa ...... for a maturation arrest at the
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Late-onset neutropenia associa ...... ocyte stage of granulopoiesis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698